Anna Polak
Warsaw, MZ 04141, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).
Journal: Cell death & disease
Published: July 31, 2025
Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells.
Journal: Cancers
Published: February 04, 2020
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Journal: Cell death & disease
Published: January 29, 2020
BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells.
Journal: Molecular oncology
Published: November 18, 2019
Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.
Journal: Journal of cellular and molecular medicine
Published: October 02, 2017
MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells.
Journal: Experimental hematology
Published: June 02, 2016
MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
Journal: PloS one
Published: November 09, 2015
FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.
Journal: Oncogene
Published: September 09, 2015
Last Updated: 09/26/2026